product quality review
TRANSCRIPT
8/21/2019 Product Quality Review
http://slidepdf.com/reader/full/product-quality-review 1/10
Product Quality Review[Product Name Dosage Strength Dosage Form]
N PQR_XXX_YYYY
Period: DD/MM/YYYY - DD/MM/YYYY
Disiapkan Oleh :
Prepared By Tanggal
Date
Disetujui Oleh :
Approved By Tanggal
Date
Disetujui Oleh :
Approved By Tanggal
Date
Disetujui Oleh :
Approved By Tanggal
Date
Disetujui Oleh :
Approved By Tanggal
Date
Disetujui Oleh :
Approved By
Tanggal
Date
8/21/2019 Product Quality Review
http://slidepdf.com/reader/full/product-quality-review 2/10
Product Quality Review[Product Name Dosage Strength Dosage Form]
1. Corrections
Onl! appli"a#le $or su#se%uent &ersion in "ase an error is noti"ed or additionalin$or'ation #e"o'es a&aila#le a$ter appro&al and distri#ution(
2. General Information
Pro&ide a short s!nopsis o$ the report "ontain the produ"t des"ription) the 'anu$a"turingsite) and the re&ie* period(
Rationale *h! the re&ie* period has #een shortened or e+tended(
3. Executive summary
,u''arie the out"o'e o$ the re&ie* in"luding "orre"ti&e a"tions $ro' pre&ious reportsthat *ere i'ple'ented in this re&ie* period) an! signi$i"ant issues or "hanges reportedin this reporting period. There should #e a "lear state'ent on the "urrent status o$ theprodu"t regarding the status o$ "ontrol) pro"ess "apa#ilit! and state o$ "o'plian"e(
4. atc!es manufactured
ist o$ all #at"hes 'anu$a"tured) released) pending release) and nu'#ers in"luding$ailed #at"hes/reje"tions during the re&ie* period $or spe"i$i" produ"t. 0aps in #at"hnu'#ering) e.g. due to &alidation lots pending appro&al or orders are "an"elled #e$ore
an! produ"tion "o''en"ed) 'ust #e e+plained in detail 1Ta#le 2-D(
"a#le 3$1 atc!es %anufactured
%aterial&ame
%aterial&o.
atc!es%anufactured
atc!esReleased
atc!es Pendin'Release
atc!esRe(ected
ist all #at"hes that *ere re*orked or repro"essed during the re&ie* period) in"luding ades"ription o$ the steps taken to re*ork or repro"essing and the pro"edure nu'#er used1Ta#le 2-34(
"a#le 3$2 Rewor) or Re*rocessin'
%aterial&ame %aterial&o. atc!&o.
+escri*tion of t!e
Rewor), Re*rocess-*eration
ProcedureReference %aterialtatus +eviationReference
Des"ri#e the produ"tion pro"ess $lo* diagra'(
8/21/2019 Product Quality Review
http://slidepdf.com/reader/full/product-quality-review 3/10
Product Quality Review[Product Name Dosage Strength Dosage Form]
/. tartin' %aterials and 0endor Performance
This se"tion is a su''ar! on %ualit! o$ starting 'aterials and supplier %ualit!per$or'an"e(
/.1 &ew ources
ist and report all ra* 'aterials 15P6s) e+"ipient and pa"kaging 'aterials4 i$ pur"hased $ro' ne* sour"e $or the 'anu$a"turing o$ the produ"t "on"erned and listthe status o$ the 'anu$a"turer 1Ta#le 7-84(
"a#le 4$1 tartin' %aterial &ew ources -ri'inal manufacturer
%aterial &ame %aterial &o. %anufacturer &ame %anufacturer tatus udit tatus
/.2 0endor Performance
ist the 'aterial na'e) 'aterial nu'#er) 'anu$a"turer 6d) 'anu$a"turer status as*ell as nu'#er o$ #at"hes re"ei&ed) released) pending release and reje"ted duringthe re&ie* period and list all de&iation related to supplier to assess the per$or'an"eo$ &endor 1Ta#le 7-34(
"a#le 4$2 Raw %aterial Received
%ateria
l &ame
%ateria
l &o.
%anufacture
r &ame
%anufacture
r
tatus
udit
tatu
s
&um#er
of
#atc!es
Receive
d
&um#er
-f
at!es
Released
&um#er
of
Pendin'
Release
&um#er
of at!es
Re(ected
. nalytical +ata and "rend nalysis
ist the Testing Monographs that ha&e #een applied 1Ta#le 9-84 and short "on"lusiona#out data %ualit! and trends(
"a#le /$1 "estin' %ono'ra*!s
%aterial &ame %aterial &o. +ocument Code Im*lementation +ate
.1 nalytical +ata for Quality Parameters
Pro&ide a &isual trending o$ the data using "ontrol "hart and an o&erall state'ent asto the degree o$ pro"ess "ontrol o#ser&ed during the re&ie* period(
8/21/2019 Product Quality Review
http://slidepdf.com/reader/full/product-quality-review 4/10
Product Quality Review[Product Name Dosage Strength Dosage Form]
/.1.1 IPC$data
Des"ri#e all "riti"al in-pro"ess "ontrols and $inished produ"t results. +plain de&iations and"orre"ti&e a"tion i$ appli"a#le(
"a#le /$2 IPC Results
ta'e of t!e*rocess
Critical Parameter cce*tance Criteria ctual Results Remar)
/.1.2 %icro#iolo'ical +ata
;o''ent on the o&erall per$or'an"e o$ the 'i"ro#iologi"al data(
/.1.3 nalytical %et!od "rends 5or Release atc!es
ist the test results and trends $ro' Q; tests $or "o''er"ial release #at"hes(.
"a#le /$3 nalytical Results
Critical Parameter cce*tance Criteria ctual Results Remar)
/.1.4 Ca*a#ility Process Evaluation
,tatisti"al anal!sis should #e used to assess pro"ess sta#ilit! and "apa#ilit!) in"ludingpro&ide "ontrol "hart into the se"tion.(
"a#le /$4 tatistical nalysis #ased on Control C!art IPC Results
&o. "est Parameter *ecification 6imit66786
Control 6imit6C6 7 8C6
Result ofControl C!art
Remar)
"a#le /$/ Process Ca*a#ility nalysis IPC Results
&o. "estParameter
*ecification6imit 66 7 86
Control 6imit6C6 7 8C6
C*value
C*)value
PP%total
i'mavalue
Remar)
"a#le /$ tatistical nalysis #ased on Control C!art nalytical Results
&o. "est Parameter *ecification 6imit66 7 86
Control 6imit6C6 7 8C6
Result ofControl C!art
Remar)
8/21/2019 Product Quality Review
http://slidepdf.com/reader/full/product-quality-review 5/10
Product Quality Review[Product Name Dosage Strength Dosage Form]
"a#le /$9 Process Ca*a#ility nalysis nalytical Results
&o."estParameter
*ecification 6imit66 7 86
Control 6imit6C6 7 8C6
C*value
C*)value
PP%total
i'mavalue
Remar)
.2 Results of t!e Product ta#ility %onitorin' Pro'ram
ist all #at"hes enrolled in the produ"t sta#ilit! progra' 1Ta#le 9-<4. ,u''arie sta#ilit!data o$ all #at"hes on sta#ilit!. ,tatisti"al anal!sis 'ust #e used to e&aluate theade%ua"! o$ "urrent internal release li'its(
"a#le /$: ta#ilities tudies
%aterial &ame %aterial &o. atc! &o. tudy "y*e "ime Point Condition
"a#le /$; tatistical nalysis #ased on Control C!art ta#ility Results
&o.ta#ilityPro'ram
"estParameter
*ecification6imit 66 7 86
Control 6imit6C6 7 8C6
Result ofControl C!art
Remar)
"a#le /$1< Process Ca*a#ility nalysis ta#ility Results
&o.ta#ilityPro'ram
"estParameter
*ecification 6imit 66786
Control 6imit6C678C6
C*value
C*)value
PP%total
i'mavalue
Remar)
.3 -ut of *ecifications
ist the nu'#er o$ "on$ir'ed and un-"on$ir'ed OO,) in"luding the root "ause) "orre"ti&eand pre&enti&e a"tions 1Ta#le 9-884(
"a#le /$11 -- -verview "a#le
%aterial&ame
%aterial&o.
&um#er of --
Confirmed,8ncorfimed
Reference to+eviation &o.
RootCause
CP
8/21/2019 Product Quality Review
http://slidepdf.com/reader/full/product-quality-review 6/10
Product Quality Review[Product Name Dosage Strength Dosage Form]
"a#le /$12 -- tatus
&o. !ort +escri*tion tatus
9. +eviations
ist all "riti"al and not "riti"al de&iations 1Ta#le =-84(
"a#le $1 +eviation -verview "a#le
&o.
%aterial
&ame %aterial &o.
atc!
&o.
6ocal
atc! &o.
&um#er of
+eviations
Critically
Critical,&on$critical
+efect
"y*e
>or all "riti"al and non-"riti"al de&iations) pro&ide a short des"ription) root "ause and ;5P51Ta#le =-34(
"a#le $2 Critical +eviations
&o. !ort +escri*tion Root Cause CPtatus of +eviationRe*ort
"a#le $3 &on$Critical +eviations
&o. !ort +escri*tion Root Cause CPtatus of +eviationRe*ort
:. C!an'es to Process and nalytical %et!ods and *ecifications
:.1 Process C!an'es
Pro&ide the su''ar! in ta#le $or'at 1Ta#le ?-84 or state that no pro"ess "hanges ha&e#een per$or'ed in"luding 'aterial and 'anu$a"turing e%uip'ent(
"a#le 9$1 ummary of Process C!an'es
C!an'e &o. C!an'e "y*e !ort +escri*tion +ate of **roval tatus Remar)
8/21/2019 Product Quality Review
http://slidepdf.com/reader/full/product-quality-review 7/10
Product Quality Review[Product Name Dosage Strength Dosage Form]
:.2 nalytical C!an'es
Pro&ide the su''ar! in ta#le $or'at 1Ta#le ?-34 or state that no anal!ti"al "hanges ha&e#een per$or'ed(
"a#le 9$2 ummary of nalytical C!an'es
C!an'e &o. C!an'e "y*e !ort +escri*tion +ate of **roval tatus Remar)
:.3 *ecification C!an'es
Pro&ide the su''ar! in ta#le $or'at 1Ta#le ?-24 or state that no spe"i$i"ation "hanges ha&e#een per$or'ed(
"a#le 9$3 ummary of *ecifications C!an'es
C!an'e &o. C!an'e "y*e !ort +escri*tion +ate of **roval tatus Remar)
:.4 -t!er C!an'es
Pro&ide the su''ar! in ta#le $or'at 1Ta#le ?-74 or state that no other "hanges ha&e #eenper$or'ed(
"a#le 9$4 ummary of -t!er C!an'es
C!an'e &o. C!an'e "y*e !ort +escri*tion +ate of **roval tatus Remar)
;. 0alidation Review
5ll &alidation a"ti&ities per$or'ed during the re&ie* period 'ust #e listed 1Ta#le 8@-84)in"luding the reason) #at"h and re$eren"e to the &alidation report) it in"ludes details o$ an!pro"ess &alidation a"ti&ities per$or'ed during the re&ie* period 1'anu$a"turing pro"esses)"leaning pro"edures) la#orator! 'ethods) reason $or re&alidation and results o$ &alidation4(
8/21/2019 Product Quality Review
http://slidepdf.com/reader/full/product-quality-review 8/10
Product Quality Review[Product Name Dosage Strength Dosage Form]
"a#le :$1 ummary of 0alidation ctivities
Process te* 0alidation +ocument Reference tatus
1<. Qualification tatus of Relevant E=ui*ment and 8tilities
Quali$i"ation status o$ rele&ant 1'ajor4 e%uip'ent and utilities 'ust #e listed *ith "hangesand de&iations to the %uali$i"ation status su''aried 1Ta#le A-84. The #asis $or the re&ie*should #e the "urrent &alidation 'aster plan(
"a#le ;$1 ummary of Qualified E=ui*ment and 8tilities
E=ui*ment, 8tilityI+E=ui*ment
Qualificationtatus
C!an'e,+eviation
&extQualification
11. Review of Quality tec!nical a'reements
Qualit! 5gree'ents *ith "ontra"tors or suppliers should #e re&ie*ed $or up-to-dateness
1'anu$a"turer "ontra"tor) test la#) supplier RM/PM4) in"ludes internal ,ando 5gree'ent1Ta#le 8@-84(
"a#le 1<$1 Quality 'reement
&ame of Contractor,ando> ffiliates
Reference +ate of review 0alid ?es, &o Remar)
12. Com*liance wit! )ey re'ulation attri#utes
Pro&ide a state'ent on the status o$ "o'plian"e $or the &eri$i"ations o$ the ke! regulator!attri#utes at a 'ini'u'. 5ppropiate a"tions are to #e "reated $or an! identi$ied "o'plian"egaps. The DR5 is responsi#le to pro&ide input on post 'arketing "o''it'ents.
+a'ples:
The re&ie* o$ the site do"u'entation against registratioon dossiers *as per$or'ed and$ound to #e "o'pliant an satis$a"tor!.
Or
8/21/2019 Product Quality Review
http://slidepdf.com/reader/full/product-quality-review 9/10
Product Quality Review[Product Name Dosage Strength Dosage Form]
The re&ie* o$ the site do"u'entation against registration dossiers *as per$or'ed and thegaps identi$ied are #eing re'ediated &ia "hange "ontrol s!ste'(
"a#le 11$1 @ey Re'ulatory ttri#utes
%anufacturin' ite&ame
6ocationPac)a'in'ite
6ocation!elf 6ife
+escri*tion of%anufacturin'Process
nalytical"est ite
6ocation+escri*tionof ProcessControls
5ll in$or'ation regarding su#'itted) granted or re$used 'arketing authoriations and post-'arketing "o''it'ents $or ne* 'arketing authoriations and &ariations to 'arketingauthoriations should #e listed. The DR5 is responsi#le to pro&ide input regarding su#'itted)granted or re$used 'arketing authoriations and &ariations there o$(
12. Com*laints
12.1 "ec!nical Com*laints
ist all te"hni"al "o'plaints during the re&ie* period. ;on"lusion 'ade as a result o$ thein&estigation should #e in"luded 1Ta#le 83-84. Medi"al "o'plaints *hi"h results in te"hni"al"o'plaint e&aluation are in"luded in the o&erall list and su''ar!(
"a#le 12$1 ummary of "ec!nical Com*laints
Com*laint&o.
%aterial&ame
%aterial&o.
atc!&o.
!ort+escri*tion
RootCause
CP Conclusion
12.2 %edical Com*laints dverse Event
Pro&ide a state'ent on 'edi"al "o'plaints and the "orresponding e&aluation(
13. ReturnA RecallsA %ar)et Bit!drawalsA Re'ulatory lert
13.1 Returned Products
ist an! returned drug produ"ts. The list should in"lude the #at"h nu'#er and reason $or returning) in&estigation and $inal de"ision and also "orre"ti&e and pre&enti&e a"tion *hi"hhad #een done 1Ta#le 82-84(
"a#le 13$1 ummary of Returned Product
atc! &o. "otal &um#er of Returned Reason
8/21/2019 Product Quality Review
http://slidepdf.com/reader/full/product-quality-review 10/10
Product Quality Review[Product Name Dosage Strength Dosage Form]
13.2 Recalls or %ar)et Bit!drawals
ist an! #at"hes *ithdra*als or re"alls) along *ith the reason $or re"all or *ithdra*al 1Ta#le
82-34(
"a#le 13$2 ummary of Recalls
atc! &o. "otal &um#er of Recalls Reason
14. ction "a)en 5ollowin' Previous PQR
,u''ar! and status o$ a"tions taken 1in"luding re&alidation a"ti&ities4 $ollo*ing the
"on"lusions and re"o''endations $ro' pre&ious PQR. 5n! ongoing ;o'plian"e or
re'ediation a"ti&ities are re&ie*ed) and an! o&erdue a"tions identi$ied(
1/. nnual 0isual Examination of Retain am*les of 5inis!ed Products 5or 8 PR
only
Per$or' a &isual e+a'ination on retain sa'ple and re&ie* the result on "on$or'an"e to the
spesi$i"ations. +a'ination per$or' onl! $or e+ported produ"t to B,5 or #e"ause other spe"i$i" reason 1"urrentl! not re%uired4(
1. Conclusions and Recommendations
1.1 de=uancy of Previous Recommendations
Pro&ide a state'ent on the su""es o$ "orre"ti&e a"tion in the last reporting period(
1.2 Conclusions and &ew Recommendations
&aluate all datas as a *hole. ,u''arie and re"o''endate these data $or a"tions)
in"luding re&alidation a"ti&ities i$ needed(
"a#le 1$1 CP PIan
ction +escri*tions PIC +ue +ate
19. nnexes
1:. +istri#ution